ClinicalTrialsFinder
RecruitingPhase 4NCT06580782

Calcium Carbonate to Augment Labor Contractions

Sponsor

Weill Medical College of Cornell University

Enrollment

60 participants

Start Date

Nov 18, 2024

Study Type

INTERVENTIONAL

Conditions

labor inductionLabor DystociaLabor Augmentation

Summary

The investigators think that calcium carbonate can act as an assistive medication to improve contractions during labor.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Calcium Carbonate 500 MG and a drug called Standard Dose Synthetic Pitocin for people with labor augmentation, labor dystocia, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGCalcium Carbonate 500 MG

Calcium Carbonate 500mg, orally, every 4 hours.

DRUGStandard Dose Synthetic Pitocin

The participant will receive thestandard-dose synthetic oxytocin for labor induction or augmentation.

Locations(1)

Weill Cornell Medicine

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06580782

Related Trials

Pain Control for Cervical Ripening Balloon

NCT072681181 location

Cervical Ripening Balloon, 3 Hours vs 12 Hours Placement

NCT076893571 location

The Effect of Reflexology on Time to Delivery During Induction of Labor

NCT071681871 location

Anticholinergics for Cervical Edema in Labor

NCT067026701 location

Early Diagnosis and Intervention for Fetal Malposition in Active Labor and Its Impact on Mode of Delivery

NCT058816291 location